Anavex Life Sciences Achieves Breakthrough in Alzheimer’s Research
OnAnavex Life Sciences has announced promising results from its recent Phase 2b/3 clinical trial investigating their novel agent, blarcamesine (ANAVEX2-73), for the treatment of.
Read More